7 completed, 2 not yet recruiting, 1 active not recruiting, 1 recruiting. 14 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Completed 7, Not yet recruiting 2, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
Follow Cannabidiol: new trials by email Literature Review of Cannabidiol trials Research Report on Cannabidiol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex Epidiolex 100 mg/mL Oral Solution - Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS) | Phase 4 | Not yet recruiting | Elizabeth Donner | 25 | 2027-01-01 | 2026-09-11 |
| A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS Cannabidiol Oral Solution - Lennox-Gastaut Syndrome | Phase 4 | Not yet recruiting | Jazz Pharmaceuticals | 40 | 2026-11-18 | 2026-11-17 |
| Investigating the Effects of Cannabidiol on Social Anxiety Disorder Cannabidiol, Placebo - Phobia, Social | Phase 4 | Recruiting | Massachusetts Institute of Technology | 50 | 2025-07-10 | 2026-08-11 |
| A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex Cannabidiol Oral Solution [Epidiolex] - Tuberous Sclerosis Complex Associated Neuropsychiatric Disease | Phase 4 | Completed | Jazz Pharmaceuticals | 79 | 2023-06-29 | 2026-04-27 |
| Cannabidiol for Bilateral Total Knee Arthroplasty cannabidiol, Ora-sweet SF - Pain, Postoperative, Opioid Use | Phase 4 | Completed | Hospital for Special Surgery, New York | 37 | 2022-11-02 | 2026-05-26 |
| Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV CBD oil - Chronic Inflammation | Phase 4 | Completed | University of Florida | 4 | 2022-05-01 | 2023-12-28 |
| Epidiolex® for Anxiety in Pediatric Epilepsy Cannabidiol 100 MG/ML - Anxiety, Epilepsy | Phase 4 | Completed | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 20 | 2022-04-05 | 2025-07-02 |
| Epidiolex in Typical Absence Seizures Cannabidiol (Epidiolex) - Study the Efficacy of Epidiolex for Typical Absence Seizures | Phase 4 | Completed | University of South Florida | 14 | 2021-07-30 | 2023-07-11 |
| Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution Cannabidiol - Lennox Gastaut Syndrome, Dravet Syndrome | Phase 4 | Active not recruiting | Jazz Pharmaceuticals | 154 | 2021-07-07 | 2026-08-26 |
| The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive Impairment Cannabidiol Oil, Homotaurine - Mild Cognitive Impairment | Phase 4 | Unknown | Aristotle University Of Thessaloniki | 90 | 2021-04-01 | 2021-08-26 |
| Cannabidiol and CES1 Interactions in Healthy Subjects dl-Methylphenidate plus Cannabidiol, dl-Methylphenidate plus Cannabidiol Placebo solution - Drug Interaction | Phase 4 | Completed | University of Florida | 14 | 2021-02-25 | 2024-07-18 |
| Investigation of Cognitive Outcomes With Cannabidiol Oral Solution GWP42003-P - Lennox-Gastaut Syndrome | Phase 4 | Withdrawn | Jazz Pharmaceuticals | 2020-10-01 | 2022-09-01 | |
| Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction Cannabidiol Oil, Placebo, Combined oral contraceptive pill - Contraception | Phase 4 | Completed | Oregon Health and Science University | 9 | 2020-04-08 | 2023-07-11 |
| Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain Cannabidiol - Back Pain, Low | Phase 4 | Terminated | Massachusetts General Hospital | 7 | 2019-11-13 | 2022-05-04 |
Lennox Gastaut Syndrome (4) · Epilepsies, Myoclonic (2) · Epilepsy (2) · Seizures (2) · Tuberous Sclerosis (2) · Anxiety Disorders (1) · Behavior (1) · Cognitive Dysfunction (1) · Liver Cirrhosis (1) · Low Back Pain (1) · Osteoarthritis, Knee (1) · Pain, Postoperative (1) · Phobia, Social (1) · Psychological Well-Being (1)
Jazz Pharmaceuticals (4) · University of Florida (2) · Aristotle University Of Thessaloniki (1) · Elizabeth Donner (1) · Hospital for Special Surgery, New York (1) · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1) · Massachusetts General Hospital (1) · Massachusetts Institute of Technology (1) · Oregon Health and Science University (1) · University of South Florida (1)
United States (11) · Canada (2) · Greece (1) · Poland (1) · United Kingdom (1)
Alexandra Sideris, PhD (1) · Elizabeth Donner, MD (1) · Jay Salpekar (1) · Jodi Gilman, PhD (1) · John Gabrieli, PhD (1) · John Markowitz, Pharm.D (1) · Shaalini Ramanadhan, MD (1) · Simone Marini, PhD (1)
2023 (1)